Table 3.
Clinical Measure [mean (standard deviation)
| Variable | TKA 6 months | TKA 1 year | Control | |||
|---|---|---|---|---|---|---|
|
| ||||||
| Operated | Non-operated | Operated | Non-operated | Operated | Non-operated | |
|
|
||||||
| KOS | 0.86 (0.09) | 0.93 (0.06) | 0.85 (0.11) | 0.91 (0.12)# | 0.99(0.02) | 0.99(0.02)γ |
| Knee pain | 0.86 (0.70) | 0.50 (0.73) | 0.77 (0.96) | 0.65 (1.02)# | 0.1(0.31) | 0.05(0.23)γ |
| Flexion ROM (°) | 118 (8) | 131(9) | 120 (9) | 130(10)* | 134.4(7.46) | 135.95(6.85) |
| Extension ROM (°)§ | 0 (4) | –2 (3) | 0 (3.56) | –1 (3)* | –0.5(2.76) | –0.55(2.98) |
| Quadriceps strength (N/BMI) | 18.81 (6.65) | 21.86 (8.67) | 18.07 (7.8) | 21.09 (8.53) | 30.08(10.22) | 29.04(9.17) |
| TUG (seconds) | 8.21 (1.62) | 7.93 (1.84) | 6.55(1.19) | |||
| SCT (seconds) | 13.28 (3.14) | 12.51 (3.26) | 8.85(1.37) | |||
| 6MW (meter) | 563.74 (82.94) | 558.52 (88.71) | 685.23(112.12) | |||
#
Data from 26 subjects;
*
data from 27 subjects;
γ
data from 19 subject;
§
negative values indicate knee hyperextension.